Last update 08 May 2025

Retinset SL

Private Company

Overview

Tags

Eye Diseases
Endocrinology and Metabolic Disease
Cardiovascular Diseases
Chemical drugs
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Chemical drugs2
Small molecule drug1

Related

3
Drugs associated with Retinset SL
BSL01
Target-
Mechanism-
Active Org.
Retinset SL
Originator Org.
Retinset SL
Active Indication
Diabetic Retinopathy
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
BSL02
Target-
Mechanism-
Active Org.
Retinset SL
Originator Org.
Retinset SL
Active Indication
Glaucoma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
BSL03
Target-
Mechanism-
Active Org.
Retinset SL
Originator Org.
Retinset SL
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Retinset SL
NCT04068272
/ CompletedPhase 1
Masked, Placebo Controlled, Phase I Trial to Assess the Safety of Bosentan 5 mg/ml Ophthalmic Eyewash in Type II Diabetic Patients
100 Clinical Results associated with Retinset SL
Login to view more data
0 Patents (Medical) associated with Retinset SL
Login to view more data
100 Deals associated with Retinset SL
Login to view more data
100 Translational Medicine associated with Retinset SL
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Nov 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
BSL01
Diabetic Retinopathy
More
Phase 1
BSL02
Glaucoma
More
Preclinical
BSL03
-
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free